May 2007
Worldwide Biotech;May2007, Vol. 19 Issue 5, p3
Trade Publication
This article discusses the enrollment of the first heart attack patient in a study from Cardium Therapeutics and its subsidiary InnerCool Therapies aimed at assessing the safety and potential use of early and rapid cooling of heart attack patients. The Rapid Intravascular Cooling in Myocardial Infarction as Adjunctive to Percutaneous Coronary Intervention trial will test the utility of InnerCool's endovascular catheter-based temperature modulation system in treating heart attack patients.


Related Articles

  • RAPID MI-ICE enrolls 1st MI patient for cooling therapy.  // Medical Technology & Devices Week;3/26/2007, Vol. 5 Issue 13, p5 

    The article reports on the enrollment of the first patient in the Rapid Intravascular Cooling in Myocardial Infarction (MI) as Adjunctive to Percutaneous Coronary Intervention study by Cardium Therapeutics and its subsidiary InnerCool Therapies. The safety and potential utility of rapid cooling...

  • 2009 - Early transfer for angiography after fibrinolysis reduced ischemic events in patients with STEMI. Borzak, Steven; Cantor, W. J. // ACP Journal Club;11/17/2009, Vol. 151 Issue 5, p2 

    The article reports on a clinical trial on patients with ST-segment elevation myocardial infarction (STEMI) to study the effectiveness of early transfer for angiography and percutaneous coronary intervention (PCI). ST-segment elevation of 2 mm in 2 anterior leads or 1 mm in 2 inferior leads were...

  • Latest Advances in Aggressive Lipid Management. Loggia, Joseph // Formulary;Mar2005 Supplement 1, Vol. 40, p2 

    The article provides information about a clinical trial related to coronary heart disease (CHD). The article states that successful completion of this clinical trial will enable the pharmacists and physicians to relate the most data from major clinical trials to the treatment of patients at risk...

  • Regado Launches Phase III Trial Testing First-in-Class Clotbuster. Shaffer, Catherine // BioWorld Today;9/18/2013, Vol. 24 Issue 179, p1 

    The article focuses on the Phase III Regulate-percutaneous coronary intervention (PCI) trial for antithrombotic drug, REG1, launched by Regado Biosciences Inc. in Basking Ridge, New Jersey. It says that the trial was conducted to a patient who is under PCI. It states that the trial will compare...

  • Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction: Are All HMG-CoA Reductase Inhibitors Alike? Maroo, Bijesh P.; Lavie, Carl J.; Milani, Richard V. // Drugs & Aging;2008, Vol. 25 Issue 8, p649 

    Cardiovascular disease remains the leading cause of mortality in elderly patients. While coronary heart disease (CHD) morbidity and mortality have decreased over the last 25 years, the percentage reduction in elderly patients is nearly 50% lower than that for the general adult population. ...

  • AMIODARONE AND MORTALITY IN CHF AND POST-MI. Zamorski, Mark // Journal of Family Practice;Mar1998, Vol. 46 Issue 3, p196 

    This article focuses on a research related to the effect of prophylactic amiodarone on mortality after acute myocardial infarction (AMI) and in congestive heart failure (CHF). Sudden cardiac death is a common cause of death following AMI and in CHF. The infamous Cardiac Arrhythmia Suppression...

  • Î’-Blockers decrease cardiac events in major noncardiac surgery. Johnson, Wesley D.; Korsen, Neil // Journal of Family Practice;Jun2002, Vol. 51 Issue 6, p507 

    The article discusses research on the effect of β-blockers on cardiac events in major noncardiac surgery. It references a study by A. D. Auerbach et al in the 2002 issue of the "Journal of the American Medical Association." Cardiac revascularization is often considered to reduce...

  • Prevalence of asymptomatic coronary heart disease in the siblings of young myocardial infarction patients. Shah, N.; Soon, K.; Wong, C.; Kelly, A. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS162 

    No abstract available.

  • Coronary Heart Disease and Depression: A Review of Recent Mechanistic Research. Skala, Judith A.; Freedland, Kenneth E.; Carney, Robert M. // Canadian Journal of Psychiatry;Oct2006, Vol. 51 Issue 12, p738 

    Objective: Both behavioural and physiological factors have been proposed as mechanisms that may explain the negative effect of depression on coronary heart disease (CHD). Our aim is to review some of the most important findings since our prior review. Method: We searched MEDLINE, PsycINFO, and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics